Do older adults get vaccines every 3-4 months?
Recommended vaccines for older adults may average one dose every few months, including flu, COVID, shingles, and RSV. Doses are not evenly spaced.
We debunk the latest vaccine misinformation each week in our Just the Facts: Correcting this week’s disinformation newsletter. Browse the other Just the Facts Newsletter Topics by clicking the link below:
Recommended vaccines for older adults may average one dose every few months, including flu, COVID, shingles, and RSV. Doses are not evenly spaced.
Dr. Simone Gold posted a video that claims even though pregnant women were once warned to avoid things like sushi and wine, they are now being told to get four vaccines during pregnancy, including one the she says cannot be "turned off."
Earlier this month, federal health officials announced changes to the U.S. childhood immunization schedule. Several vaccines that were previously recommended for all children are now listed as either recommended only for certain high-risk groups or as vaccines that require “shared…
Do kids really get 76 vaccines? Nope. We clarify the actual childhood vaccine schedule and how the schedule has changed slowly and carefully over time—not suddenly or dangerously.
RSV vaccines during pregnancy are safe and protect newborns. Learn how they work, debunked claims about preterm birth, and what the latest studies show.
Did RSV cause a recent measles death? Anti-vaxxers deflect blame, but officials confirm measles was the cause. Learn the facts about measles, RSV, and vaccination.
RSV has long been recognized as a health risk for seniors and immunocompromised adults, with studies dating back to the 1980s identifying severe complications and deaths.
Claims that RSV vaccines cause pre-term births are misleading. Studies show no increased risk, and safety data supports their use during pregnancy.
Claims that RSV vaccines given during pregnancy cause prematurity are misleading; data shows no increased risk in prematurity for vaccinated groups, but a decrease in the placebo group.
The adult RSV vaccines under development have shown promising results in clinical trials, showing an efficacy of about 85% without safety concerns.